Aardvark Therapeutics (AARD)
Develops gut-restricted oral programs for hunger-associated conditions and obesity.
$5.75
After-hours close+0.05 (+0.88%)
At close$5.70(+2.33%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 43.10% | 9.43M shares | |
|---|---|---|---|
| 75 holders · as of Jun 30, 2026 | |||
| Insiders | 22.96% | 5.02M shares | |
| 5 holders · as of Sep 11, 2026 | |||
| Strategic holders | 27.40% | 6.00M shares | |
| 3 holders · as of Feb 24, 2025 | |||
| Other | 6.54% | 1.43M shares | |
| remainder | |||
21.88M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
75 holders · 9.43M shares · 18 new positions · 39 increased · 24 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | 17.90% | 0 | Aug 14, 2026 |
| Citadel Advisors LLC | 1.28M | 5.86% | +40.4K | Sep 2, 2026 |
| Laurion Capital Management LP | 1.03M | 4.73% | 0 | Aug 13, 2026 |
| Vanguard Capital Management LLC | 562.9K | 2.57% | +8.8K | Aug 13, 2026 |
| AQR Capital Management LLC | 480.2K | 2.19% | +345.8K | Aug 14, 2026 |
| Ecor1 Capital, LLC | 396.2K | 1.81% | +396.2Knew | Aug 14, 2026 |
| Adage Capital Partners GP, L.L.C. | 300.0K | 1.37% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 187.0K | 0.85% | −605.5K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | 13.80% | 2.96M | 13G | Feb 24, 2025 |
| Tien-Li Lee | 13.70% | 2.98M | 13G | May 15, 2025 |
| Dr. Finian Tan | 8.69% | 1.83M | 13G | Feb 24, 2025 |
| Citadel Advisors LLC | 5.40% | 1.15M | 13G | Feb 24, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 11, 2026 | Nelson Sunofficer: See Remarks | Sale | 62,000 | $5.18 | 35,475 |
| Sep 10, 2026 | Nelson Sunofficer: See Remarks | Sale | 14,754 | $5.00 | 97,475 |
| Dec 11, 2025 | Tien-Li Leedirector, 10 percent owner, officer: Chief Executive Officer | Purchase | 7,000 | $14.49 | 1,551,613 |
| Dec 11, 2025 | Nelson Sunofficer: Chief Financial Officer | Purchase | 3,000 | $14.40 | 108,484 |
House and Senate disclosures
Not reported.